Credit: Getty Images. The approval was based on data from 2 pivotal phase 3 trials, which evaluated Pedmark in pediatric patients undergoing treatment with cisplatin-based chemotherapy. The Food and ...
Credit: Getty Images. Pedmark is the first FDA-approved therapy indicated to reduce the risk of cisplatin-induced hearing loss in children. Pedmark ® (sodium thiosulfate) is now available to reduce ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Sodium Thiosulfate Injection contains the active ingredient sodium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results